SCORPIUS HOLDINGS, INC.

Analyst Reco. Scorpius Holdings, Inc.

Equities

SCPX

US42237K4094

Market Closed - Nyse Other stock markets 04:10:00 2024-05-01 pm EDT			5-day change	1st Jan Change
0.1838 ^USD	-4.27%		+14.30%	-58.26%

Apr. 26	Scorpius Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 23	Scorpius Holdings Gets Non-Compliance Notice From NYSE American	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Brookline Capital Downgrades NightHawk Biosciences to Hold From Buy	23-05-01	MT
Maxim Downgrades NightHawk Biosciences to Hold From Buy	23-04-03	MT
B. Riley Lowers Heat Biologics' PT to $8 from $10, Adjusts Model for Higher Cost of Capital to Support Higher Operating Expenditures Ramp; Keeps Buy Rating	22-03-18	MT
Alliance Global Adjusts Heat Biologics' Price Target to $15.50 From $20, Reiterates Buy Rating	22-03-15	MT
B. Riley Lowers Heat Biologics' Price Target to $10 from $15 After Revising Cost Capital Assumptions, Keeps Buy Rating	22-01-24	MT
HEAT BIOLOGICS : Alliance Global Adjusts Price Target on Heat Biologics to $20 From $32, Reiterates Buy Rating	21-08-25	MT
HEAT BIOLOGICS : B. Riley Lowers Heat Biologics' PT to $15 from $20 to Reflect Increased Research and Development Investment, Keeps Buy Rating	21-08-18	MT
HEAT BIOLOGICS : Cantor Fitzgerald Starts Heat Biologics at Overweight With $22 Price Target	21-03-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer